Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Watchlist Manager
Nanjing Vishee Medical Technology Co Ltd Logo
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Watchlist
Price: 29.68 CNY 2.52% Market Closed
Market Cap: 2.8B CNY
Have any thoughts about
Nanjing Vishee Medical Technology Co Ltd?
Write Note

Nanjing Vishee Medical Technology Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vishee Medical Technology Co Ltd
Operating Income Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Operating Income
ÂĄ120.8m
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Operating Income
ÂĄ574.3m
CAGR 3-Years
69%
CAGR 5-Years
87%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Operating Income
ÂĄ1.8B
CAGR 3-Years
-2%
CAGR 5-Years
17%
CAGR 10-Years
20%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Operating Income
ÂĄ13.5B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Operating Income
ÂĄ856.6m
CAGR 3-Years
-11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Operating Income
ÂĄ1.9B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nanjing Vishee Medical Technology Co Ltd's Operating Income?
Operating Income
120.8m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vishee Medical Technology Co Ltd's Operating Income amounts to 120.8m CNY.

What is Nanjing Vishee Medical Technology Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
12%

Over the last year, the Operating Income growth was 74%. The average annual Operating Income growth rates for Nanjing Vishee Medical Technology Co Ltd have been -6% over the past three years , 12% over the past five years .

Back to Top